UK NICE Knock Back For Janssen’s ‘Game-Changing’ Darzalex Combo
Executive Summary
Draft guidance from the health technology assessment body, NICE, says that while Darzalex in combination with two other drugs is an innovative therapy for previously treated multiple myeloma, there is not enough long-term data to support its use on NHS England.